Established in 1986, we specialise in the development and manufacturing of APIs and finished dosage pharmaceutical formulations. Our values transcend mere profits and guide us in fulfilling our responsibility towards society.
This quest, for healing the world, drives our performance and helps us move towards our Vision.
We are renowned for our expertise across varied therapies such as antituberculars, antimalarials, antiretrovirals, antibacterials, antidiabetics, antihypertensives and antiasthmatics. We are also known for the largest number of WHO pre-qualified medicines, used in the treatment of HIV/AIDS, Malaria, Tuberculosis (TB) and opportunistic infections.
We manufacture close to 25 billion units of finished dosages per year. These include tablets, capsules, liquid orals, powders for oral suspension, pressurised metered dose inhalers (pMDI), single dose dry powder inhalers (DPI), dry powders for injections (antiseptic fill) and a variety of topicals like lotions, creams, ointments and gels.
Our vision is to become a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs.
To contribute towards improving patients quality of life across the globe, by providing effective and accessible medicines.
